Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (221-230 of 385) with videos related to

Pageof 39
Sort By:
Plos Computational Biology|February 2, 2024
Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematologyDaniele Dall'Olio, Eric Sträng, Amin T Turki, et al.
Haematologica|December 9, 2008
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98BRichard F Schlenk, Konstanze Döhner, Michael Kneba, et al.
Transplantation and Cellular Therapy|December 17, 2025
Pretransplant HMA and Venetoclax in AML patients - a Real-World Analysis from the Cooperative Transplant Study GroupChristina Rautenberg, Matthias Stelljes, Gesine Bug, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 20, 2022
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing ToolsFrancesco Cerisoli, Farzad Ali, Tamás Bereczky, et al.
Science Advances|July 17, 2019
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AMLJanus S Jakobsen, Linea G Laursen, Mikkel B Schuster, et al.
Blood|July 21, 2012
High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemiaKlaus H Metzeler, Bernhard Heilmeier, Katrin E Edmaier, et al.
Blood Advances|August 15, 2023
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technologyMarius-Konstantin Klever, Eric Sträng, Sara Hetzel, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Blood|January 26, 2024
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicryAmin Ben Hamza, Carlotta Welters, Serena Stadler, et al.
BMC Cancer|April 3, 2022
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancerNathanael Raschzok, Sebastian Stintzing, Volker Heinemann, et al.
Pageof 39

Showing results (221-230 of 385) with videos related to

Sort By:
Pageof 39
Plos Computational Biology|February 2, 2024
Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematologyDaniele Dall'Olio, Eric Sträng, Amin T Turki, et al.
Haematologica|December 9, 2008
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98BRichard F Schlenk, Konstanze Döhner, Michael Kneba, et al.
Transplantation and Cellular Therapy|December 17, 2025
Pretransplant HMA and Venetoclax in AML patients - a Real-World Analysis from the Cooperative Transplant Study GroupChristina Rautenberg, Matthias Stelljes, Gesine Bug, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 20, 2022
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing ToolsFrancesco Cerisoli, Farzad Ali, Tamás Bereczky, et al.
Science Advances|July 17, 2019
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AMLJanus S Jakobsen, Linea G Laursen, Mikkel B Schuster, et al.
Blood|July 21, 2012
High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemiaKlaus H Metzeler, Bernhard Heilmeier, Katrin E Edmaier, et al.
Blood Advances|August 15, 2023
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technologyMarius-Konstantin Klever, Eric Sträng, Sara Hetzel, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Blood|January 26, 2024
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicryAmin Ben Hamza, Carlotta Welters, Serena Stadler, et al.
BMC Cancer|April 3, 2022
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancerNathanael Raschzok, Sebastian Stintzing, Volker Heinemann, et al.
Pageof 39